ACH vs JNJ: Which Stock is Better?
Side-by-side comparison of Accendra Health Inc and Johnson & Johnson in 2026
ACH
Accendra Health Inc
$2.81
JNJ
Johnson & Johnson
$240.16
Key Metrics Comparison
| Metric | ACH | JNJ | Winner |
|---|---|---|---|
| Market Cap | $201.03M | $573.46B | JNJ |
| P/E Ratio | N/A | 21.55 | JNJ |
| EPS (TTM) | $N/A | $11.04 | JNJ |
| Revenue Growth | -0.7% | 0.1% | JNJ |
| Gross Margin | 46.7% | 68.1% | JNJ |
Analyze ACH
Full quant analysis
Analyze JNJ
Full quant analysis
Analyze Each Stock
Frequently Asked Questions
Is ACH or JNJ a better investment?
Comparing ACH and JNJ: Accendra Health Inc has a market cap of $201.03M while Johnson & Johnson has $573.46B. Both companies have their strengths - use our detailed metrics comparison to make an informed decision.
What is the difference between ACH and JNJ?
ACH (Accendra Health Inc) and JNJ (Johnson & Johnson) differ in valuation, growth rates, and profitability metrics. Our comparison shows which company leads in each category.
Which stock has better value: ACH or JNJ?
Based on P/E ratios, compare detailed valuation metrics on our dashboard.
Which is growing faster: ACH or JNJ?
JNJ has higher revenue growth at 0.1% vs -0.7% for ACH.
Which company is more profitable: ACH or JNJ?
Johnson & Johnson (JNJ) has higher gross margins at 68.1% compared to 46.7% for ACH.
Which is the larger company: ACH or JNJ?
Johnson & Johnson (JNJ) is larger with a market cap of $573.46B compared to $201.03M for ACH.
Should I buy ACH or JNJ in 2026?
Both ACH and JNJ have investment merit. ACH trades at $2.81 while JNJ trades at $240.16. Consider your investment goals, risk tolerance, and portfolio diversification before deciding. Our AI analysis tools can provide personalized insights.
What are the key differences between ACH and JNJ stock?
Key differences: Market Cap ($201.03M vs $573.46B), P/E Ratio (N/A vs 21.6x), Revenue Growth (-0.7% vs 0.1%), Gross Margin (46.7% vs 68.1%).